Page last updated: 2024-10-23

bromhexine and Bright Disease

bromhexine has been researched along with Bright Disease in 1 studies

Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prause, JU1
Elling, F1
Jensen, OA1
Manthorpe, R1

Other Studies

1 other study available for bromhexine and Bright Disease

ArticleYear
The effect of bromhexine on the kidney lesions in NZB-NZW-F1 mice.
    Scandinavian journal of rheumatology. Supplement, 1986, Volume: 61

    Topics: Animals; Bromhexine; Disease Models, Animal; Glomerulonephritis; Humans; Mice; Sjogren's Syndrome

1986